Search PubMed⌕ Search

Biomedical subjects

Gregor Reid

Publications and source records attributed to Gregor Reid.

58 records · Page 4Linked to original sources

Drug resistance amongst uropathogens isolated from women in a suburban population: laboratory findings over 7 years.

Urinary tract infections (UTI) are a common reason for patient visits to the family physician. The following study was carried out during one month in 1989 and one month in 1996, whereby urine specimens from adult females (living in suburban areas of Toronto, Canada), with presumed signs and symptoms of UTI, were processed. The pool of 20 infecting uropathogenic species was relatively unaltered over the seven years. Most isolates were Gram negative pathogens (72% in 1989; 76% in 1996), with Escherichia coli the most common (56.5% in 1989; 61.9%, in 1996), followed by Enterococcus faecalis (17.4% in 1989; 9.47% in 1996). The resistance to commonly prescribed trimethoprim-sulfamethoxazole increased during the seven years from 10% to 15%, for E. coli (Table 2) and from 35% to 100% for enterococci (Table 3). In 1996, although there was resistance to norfloxacin, the top five uropathogenic species were highly susceptible. No enterococci were resistant to nitrofurantoin and almost all E. coli (99.2%) were susceptible. Based upon this in-vitro data, nitrofurantoin, and not trimethoprim-sulfamethoxazole, would be the antimicrobial agent of choice for treatment of uncomplicated UTI in adult females.

Journal Article↗

Probiotics for urogenital health.

Bacterial vaginosis, urinary tract infection, and yeast vaginitis afflict an estimated 1 billion women each year. Once investigation has ruled out complicated underlying causes, the only therapeutic option is antimicrobial agents. In many cases, this is effective at clearing infection. However, recurrences, side effects, and secondary infections are frequent. Coinciding with infection is a disruption of the normal commensal microflora in the vagina, primarily a loss of lactobacilli. The exogenous application of lactobacilli to the host as probiotic agents appears to offer hope as an alternative management regimen to antimicrobial treatment and prophylaxis. Although commercial probiotics specifically selected and proven to be effective for urogenital infections are not yet available, there is growing in vitro and human data to suggest that certain strains could confer health benefits on a large number of women. Given that depleted vaginal lactobacilli and recurrent infection is associated with increased risk of sexually transmitted diseases and preterm labor, multiple antibiotic resistance, and significant reduction in quality of life, the need for probiotic therapeutics has never been greater.

Anti-Bacterial Agents↗

Rat PSP94 inhibits the growth and viability of the rat adenocarcinoma cell line PAIII in vitro.

Previous studies have shown that human PSP94 can inhibit the growth of prostate cancer cells both in vitro and in vivo. To further validate this potential and investigate the protein within a homologous setting, we examined the effects of rat PSP94 on the growth of the rat prostate adenocarcinoma cell line PAIII in vitro. To generate rat PSP94, we used both a plasmid-based expression system and a recombinant rat PSP molecule. Rat PSP was shown to inhibit the growth and survival of PAIII cells in a dose-dependent manner with > 90 percent reductions in both observed. TUNEL and Annexin-V assays confirmed PAIII cell death to be via apoptosis.

Adenocarcinoma↗